EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Global DNA Methylation in Poorly Controlled Type 2 Diabetes Mellitus: Association with Redox and Inflammatory Biomarkers

Sanja Vujcic, Jelena Kotur-Stevuljevic, Zoran Vujcic, Sanja Stojanovic, Teodora Beljic Zivkovic iD, Miljanka Vuksanovic, Milica Marjanovic Petkovic iD, Iva Perovic Blagojevic iD, Branka Koprivica-Uzelac, Sanja Ilic-Mijailovic, Manfredi Rizzo iD, Aleksandra Zeljkovic iD und 3 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26146716 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sanja Vujcic und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, University of Belgrade-Faculty of Pharmacy, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, DNA Methylation, Biomarkers, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development and Innovation, Republic of Serbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although emerging evidence suggests that epigenetic mechanisms contribute to the pathogenesis and progression of type 2 diabetes mellitus (T2DM), data remain limited for patients with suboptimal metabolic control. The aim of this study was to assess global DNA methylation in patients with poorly controlled T2DM and to identify diabetes-related factors associated with DNA methylation levels. The study included 107 patients and 50 healthy controls. Global DNA methylation (5mC) was measured by UHPLC-DAD method. Pro-oxidant and antioxidant biomarkers, advanced glycation end-products, high-sensitivity C-reactive protein (hsCRP) and complete blood count were determined and leukocyte indices calculated. Patients had a significantly lower 5mC than controls (3.56 ± 0.31% vs. 4.00 ± 0.68%; p < 0.001), with further reductions observed in those with longer disease duration and diabetic foot ulcers. Oxidative stress and inflammatory biomarkers were higher in the patient group. DNA hypomethylation was associated with a higher monocyte-to-lymphocyte ratio and hsCRP, pro-oxidant–antioxidant balance, ischemia-modified albumin, and advanced oxidation protein products levels. Conversely, 5mC levels showed positive correlations with total antioxidant status and total sulfhydryl groups. Principal component analysis identified five key factors: proinflammatory, pro-oxidant, aging, hyperglycemic, and antioxidant. The pro-oxidant factor emerged as the sole independent predictor of global DNA hypomethylation in T2DM (OR = 2.294; p = 0.027). Our results indicate that global DNA hypomethylation could be a biomarker of T2DM progression, reflecting the complex interactions between oxidative stress, inflammation, and epigenetic modifications in T2DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2DNA MethylationBiomarkersInflammationHumansMaleFemaleMiddle AgedOxidation-ReductionOxidative StressAgedC-Reactive ProteinCase-Control StudiesEpigenesis, GeneticGlycation End Products, AdvancedAdult

Stichwörter der Autor:innen

biomarkersdiabetes mellitusglobal DNA methylationinflammationoxidative stress

Substanzen

BiomarkersC-Reactive ProteinGlycation End Products, Advanced

Autor:innen und Institutionen

  • Department of Medical Biochemistry, University of Belgrade-Faculty of Pharmacy, 11000 Belgrade, Serbia.
  • Department of Biochemistry, University of Belgrade-Faculty of Chemistry, 11000 Belgrade, Serbia.
  • Department of Chemistry, University of Belgrade-Institute of Chemistry, Technology and Metallurgy, 11000 Belgrade, Serbia.
  • Department of Internal Medicine, University of Belgrade-Faculty of Medicine, 11000 Belgrade, Serbia.
  • Division of Endocrinology, Diabetes and Metabolic Disorders, Department of Internal Medicine, Zvezdara University Medical Center, 11000 Belgrade, Serbia.
  • Clinical Hospital Center "Dr. Dragisa Misovic-Dedinje", 11000 Belgrade, Serbia.

ORCID-Profile: Teodora Beljic Zivkovic, Milica Marjanovic Petkovic, Iva Perovic Blagojevic, Manfredi Rizzo, Aleksandra Zeljkovic

Förderung

  • Ministry of Science, Technological Development and Innovation, Republic of Serbia

Zitieren

APA

Vujcic, S., Kotur-Stevuljevic, J., Vujcic, Z., Stojanovic, S., Beljic Zivkovic, T., Vuksanovic, M., Marjanovic Petkovic, M., Perovic Blagojevic, I., Koprivica-Uzelac, B., Ilic-Mijailovic, S., Rizzo, M., Zeljkovic, A., Stefanovic, T., Bosic, S., & Vekic, J. (2025). Global DNA Methylation in Poorly Controlled Type 2 Diabetes Mellitus: Association with Redox and Inflammatory Biomarkers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146716

Vancouver

Vujcic S, Kotur-Stevuljevic J, Vujcic Z, Stojanovic S, Beljic Zivkovic T, Vuksanovic M, et al. Global DNA Methylation in Poorly Controlled Type 2 Diabetes Mellitus: Association with Redox and Inflammatory Biomarkers. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146716

BibTeX
@article{Vujcic2025,
  author = {Vujcic, Sanja and Kotur-Stevuljevic, Jelena and Vujcic, Zoran and Stojanovic, Sanja and Beljic Zivkovic, Teodora and Vuksanovic, Miljanka and Marjanovic Petkovic, Milica and Perovic Blagojevic, Iva and Koprivica-Uzelac, Branka and Ilic-Mijailovic, Sanja and Rizzo, Manfredi and Zeljkovic, Aleksandra and Stefanovic, Tatjana and Bosic, Srecko and Vekic, Jelena},
  title = {Global DNA Methylation in Poorly Controlled Type 2 Diabetes Mellitus: Association with Redox and Inflammatory Biomarkers},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26146716}
}
Kostenlos starten →